Institution · Netherlands Pharmacovigilance Centre Lareb
Most cited papers from Netherlands Pharmacovigilance Centre Lareb
What are the most cited papers from Netherlands Pharmacovigilance Centre Lareb?
The most cited paper from Netherlands Pharmacovigilance Centre Lareb is "A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions" (Eugène van Puijenbroek, Andrew M. Bate, Hubert G.M. Leufkens et al., 2002), with 1,385 citations. Next come "Medication use in pregnancy: a cross-sectional, multinational web-based study" (512) and "The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration" (332).
Showing 50 of 59 papers. Every paper with more than 71 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions Eugène van Puijenbroek, Andrew M. Bate, Hubert G.M. Leufkens et al. · Pharmacoepidemiology and Drug Safety | 2002 | 1,385 |
| 2 | Medication use in pregnancy: a cross-sectional, multinational web-based study Angela Lupattelli, Olav Spigset, Michael James Twigg et al. · BMJ Open | Feb 2014 | 512 |
| 3 | The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration Michele Fusaroli et al. · Drug Safety | 7 May 2024 | 332 |
| 4 | Pharmacovigilance: methods, recent developments and future perspectives Linda Härmark, A.C. van Grootheest · European Journal of Clinical Pharmacology | 3 Jun 2008 | 297 |
| 5 | Attitudinal survey of voluntary reporting of adverse drug reactions Eland, Belton, van Adrianus Grootheest et al. · British Journal of Clinical Pharmacology | Oct 1999 | 257 |
| 6 | The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement Michele Fusaroli et al. · Drug Safety | 7 May 2024 | 242 |
| 7 | Causal or Casual? Ronald H.B. Meyboom, Yechiel A. Hekster, Toine C. G. Egberts et al. · Drug Safety | Dec 1997 | 241 |
| 8 | Principles of Signal Detection in Pharmacovigilance Ronald H.B. Meyboom, Toine C. G. Egberts, Ivor Ralph Edwards et al. · Drug Safety | Jun 1997 | 238 |
| 9 | Mental health status of pregnant and breastfeeding women during the COVID‐19 pandemic—A multinational cross‐sectional study Michael Ceulemans, Veerle Foulon, Elin Ngo et al. · Acta Obstetricia Et Gynecologica Scandinavica | 21 Jan 2021 | 219 |
| 10 | Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy: A Prospective Multicenter Cohort Study Corinna Weber‐Schoendorfer et al. · Arthritis & Rheumatology | 27 Jan 2014 | 209 |
| 11 | Adverse Drug Reaction-Related Hospitalisations Cornelis S. Van Der Hooft, Miriam Sturkenboom, Kees van Grootheest et al. · Drug Safety | 2006 | 188 |
| 12 | Adverse Drug Reaction Reporting by Patients in the Netherlands Joyce de Langen, Florence P. A. M. van Hunsel, Anneke Passier et al. · Drug Safety | 2008 | 181 |
| 13 | Pharmacists' role in reporting adverse drug reactions in an international perspective Kees van Grootheest, Sten Olsson, Mary Couper et al. · Pharmacoepidemiology and Drug Safety | 15 Sep 2003 | 174 |
| 14 | Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study Sieta T. de Vries, Petra Denig, Corine Ekhart et al. · British Journal of Clinical Pharmacology | 3 Apr 2019 | 153 |
| 15 | Use of Measures of Disproportionality in Pharmacovigilance Toine C. G. Egberts, Ronald H.B. Meyboom, Eugène van Puijenbroek · Drug Safety | 2002 | 153 |
| 16 | Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study Roel de Heus, Ben W. Mol, J.J.H.M. Erwich et al. · BMJ | 5 Mar 2009 | 148 |
| 17 | Application of Quantitative Signal Detection in the Dutch Spontaneous Reporting System for Adverse Drug Reactions Eugène van Puijenbroek, Willem L. Diemont, Kees van Grootheest · Drug Safety | 2003 | 147 |
| 18 | Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation S. Michael Marcy, Katrin S. Kohl, Ron Dagan et al. · Vaccine | 14 Oct 2003 | 146 |
| 19 | Experiences with Adverse Drug Reaction Reporting by Patients Florence P. A. M. van Hunsel, Linda Härmark, Shanthi Narayan Pal et al. · Drug Safety | 8 Dec 2011 | 145 |
| 20 | Pharmacovigilance in Perspective Ronald H.B. Meyboom, Toine C. G. Egberts, Frank W.J. Gribnau et al. · Drug Safety | 1999 | 144 |
| 21 | An ABC of Drug-Related Problems Ronald H.B. Meyboom, Marie Lindquist, Toine C. G. Egberts · Drug Safety | 2000 | 137 |
| 22 | On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under‐reporting on odds ratios P.G.M. van der Heijden, Eugène van Puijenbroek, Stef van Buuren et al. · Statistics in Medicine | 19 Jun 2002 | 136 |
| 23 | Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism Cees De Baat, Merel Charlotte Verhoeff, Jari Ahlberg et al. · Journal of Oral Rehabilitation | 27 Jul 2020 | 132 |
| 24 | Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs Eugène van Puijenbroek, Toine C. G. Egberts, Eibert Roelof Heerdink et al. · European Journal of Clinical Pharmacology | 7 Nov 2000 | 130 |
| 25 | Drug-Associated Acute Pancreatitis: Twenty-One Years of Spontaneous Reporting in The Netherlands Ingo A. Eland, Eugène van Puijenbroek, Miriam Sturkenboom et al. · The American Journal of Gastroenterology | Sep 1999 | 130 |
| 26 | Guidelines for Submitting Adverse Event Reports for Publication William N. Kelly, Felix M Arellano, Joanne Barnes et al. · Drug Safety | 2007 | 129 |
| 27 | Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources Linda Davidson, Juul M. P. A. van den Reek, Mariolina Bruno et al. · The Lancet Regional Health - Europe | 22 Nov 2021 | 127 |
| 28 | Signalling possible drug–drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole Eugène van Puijenbroek, Toine C. G. Egberts, Ronald H.B. Meyboom et al. · British Journal of Clinical Pharmacology | Jun 1999 | 124 |
| 29 | Vaccine Willingness and Impact of the COVID-19 Pandemic on Women’s Perinatal Experiences and Practices—A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic Michael Ceulemans, Veerle Foulon, Alice Panchaud et al. · International Journal of Environmental Research and Public Health | 24 Mar 2021 | 118 |
| 30 | Pregnancy outcome following maternal exposure to statins: a multicentre prospective study Ursula Winterfeld, Arthur Allignol, Alice Panchaud et al. · BJOG An International Journal of Obstetrics & Gynaecology | 30 Nov 2012 | 118 |
| 31 | Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals: Fig 1 Toine C. G. Egberts, Maartje Smulders, Fred H.P. De Koning et al. · BMJ | 31 Aug 1996 | 117 |
| 32 | Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home Helga Blauw, Arianne C. van Bon, Renata Koops et al. · Diabetes Obesity and Metabolism | 21 Mar 2016 | 116 |
| 33 | Consumer Adverse Drug Reaction Reporting Kees van Grootheest, Linda de Graaf, Lolkje T.W. de Jong‐van den Berg · Drug Safety | 2003 | 115 |
| 34 | The role of hospital and community pharmacists in pharmacovigilance A.C. van Grootheest, Lolkje T.W. de Jong‐van den Berg · Research in Social and Administrative Pharmacy | Mar 2005 | 108 |
| 35 | Proton pump inhibitor‐induced acute interstitial nephritis Linda Härmark, Hans E. van der Wiel, Mark de Groot et al. · British Journal of Clinical Pharmacology | 17 Jul 2007 | 105 |
| 36 | Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti‐Inflammatory Drugs Jorieke Konijnenbelt‐Peters, Charlotte van der Heijden, Corine Ekhart et al. · Pain Practice | 27 Jun 2016 | 99 |
| 37 | The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis Leàn Rolfes, Florence P. A. M. van Hunsel, Laura van der Linden et al. · Drug Safety | 12 Apr 2017 | 95 |
| 38 | Adverse drug reactions of montelukast in children and adults Meindina G. Haarman, Florence P. A. M. van Hunsel, Tjalling W. de Vries · Pharmacology Research & Perspectives | 20 Sep 2017 | 94 |
| 39 | Hypothermia following antipsychotic drug use Rob J. van Marum, Michelle A. Wegewijs, ANTON J. M. LOONEN et al. · European Journal of Clinical Pharmacology | 30 Mar 2007 | 93 |
| 40 | Adverse Events Associated With PCSK 9 Inhibitors: A Real‐World Experience Muhammed T. Gürgöze, A H G Muller-Hansma, Michelle M. Schreuder et al. · Clinical Pharmacology & Therapeutics | 27 Jul 2018 | 91 |
| 41 | Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation Sintha D. Sie, JOHANNA M. B. WENNINK, J J van Driel et al. · Archives of Disease in Childhood Fetal & Neonatal | 18 Oct 2012 | 89 |
| 42 | Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example Florence P. A. M. van Hunsel, Anneke Passier, Kees van Grootheest · British Journal of Clinical Pharmacology | 26 Feb 2009 | 88 |
| 43 | Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases Robbert-Jan Gieselbach, A H G Muller-Hansma, Martijn T. Wijburg et al. · Journal of Neurology | 23 May 2017 | 87 |
| 44 | Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases Roderick P.P.W.M. Maas, A H G Muller-Hansma, Rianne A.J. Esselink et al. · Journal of Neurology | 11 Jul 2016 | 86 |
| 45 | Adverse drug reaction reports of patients and healthcare professionals—differences in reported information Leàn Rolfes, Florence P. A. M. van Hunsel, Sarah Wilkes et al. · Pharmacoepidemiology and Drug Safety | 31 Jul 2014 | 86 |
| 46 | Motives for reporting adverse drug reactions by patient-reporters in the Netherlands Florence P. A. M. van Hunsel, Christine M. Cramer‐van der Welle, Anneke Passier et al. · European Journal of Clinical Pharmacology | 23 Jul 2010 | 85 |
| 47 | SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland Sarah Stückelberger, Guillaume Favre, Michael Ceulemans et al. · Viruses | 22 Jun 2021 | 84 |
| 48 | QT lengthening and life-threatening arrhythmias associated with fexofenadine YM Pinto, IC van Gelder, Marten J. Heeringa et al. · The Lancet | Mar 1999 | 81 |
| 49 | Surveillance of suspected adverse reactions to natural health products in Italy Francesca Menniti‐Ippolito, Gabriela Mazzanti, Carmela Santuccio et al. · Pharmacoepidemiology and Drug Safety | 10 Mar 2008 | 81 |
| 50 | Non‐puerperal lactation associated with antidepressant drug use Toine C. G. Egberts, Ronald H.B. Meyboom, Fred H.P. De Koning et al. · British Journal of Clinical Pharmacology | Sep 1997 | 80 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.